Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease

Secondary hyperparathyroidism (sHPT) represents the adaptive and very often, finally, maladaptive response of the organism to control the disturbed homeostasis of calcium, phosphorus, and vitamin D metabolism caused by declining renal function in chronic kidney disease (CKD). sHPT leads to cardiovas...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedl, Claudia, Zitt, Emanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436758/
https://www.ncbi.nlm.nih.gov/pubmed/28546765
http://dx.doi.org/10.2147/IJNRD.S97637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436758/
https://www.ncbi.nlm.nih.gov/pubmed/28546765
http://dx.doi.org/10.2147/IJNRD.S97637

Ejemplares similares